Your Location:
Home >
Browse articles >
Shenshuai Guanchang Prescription Treats Non-dialysis Patients with Chronic Kidney Disease Stage 4-5 of Spleen and Kidney Deficiency,Blood Stasis and Dampness Turbidity: A Randomized Controlled Trial
Updated:2026-10-16
    • Shenshuai Guanchang Prescription Treats Non-dialysis Patients with Chronic Kidney Disease Stage 4-5 of Spleen and Kidney Deficiency,Blood Stasis and Dampness Turbidity: A Randomized Controlled Trial

    • “The treatment of renal failure enema can improve the clinical symptoms and intestinal barrier function of CKD stage 4-5 non dialysis patients, reduce non indole uremic toxins, alleviate micro inflammatory states, and has good clinical safety. It has opened up a new direction for traditional Chinese medicine treatment of chronic kidney disease.”
    • LI Xiangyu , ZHANG Ning , LI Tongxia , YAN Pu , ZHANG Qian , HOU Fanyu , ZHAO Zhiquan , FAN Xinrong , SHI Kaifeng
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 22, Pages: 198-208(2026)
    • DOI: 10.13422/j.cnki.syfjx.20260797     

      CLC:
    • Revised:2026-01-16 ,

      Accepted:12 February 2026 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 8 )

  • References

  • Publication Info

  • Metrics

9

Views

2

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Outcome Indicators in Randomized Controlled Trials of Traditional Chinese Medicine Intervention in Chronic Kidney Disease
A Randomized Controlled Trial on Regulation of LncRNA EBLN3P/miR-369-3p/NFIX-JAK/STAT Signaling Pathway by Huangqin Qingre Chubi Capsules to Restore Clinical and Laboratory Indicators in Patients with Rheumatoid Arthritis
Mechanisms of Dahuang Gancaotang in Improving Ferroptosis in Chronic Kidney Disease through SIRT3-mediated Deacetylation of p53
Mechanisms of Bushen Tongluo Jiangzhuo Prescription in Improving Renal Fibrosis in Rats with Chronic Kidney Disease Based on PI3K/Akt/mTOR Signaling Pathway
Clinical Efficacy of Xiaoji Hufei Formula in Protecting Children with Close Contact Exposure to Influenza: A Multicenter,Prospective, Non-randomized, Parallel, Controlled Trial

Related Author

HAN Hairui
ZHUO Zushun
LIN Long
LIN Xiangying
FENG Wenjuan
LIN Mingshan
CAI Ziyao
YANG Zhaoyang

Related Institution

Fujian Provincial Key Laboratory of TCM Health Status Identification
College of Humanities and Management, Fujian University of TCM
Traditional Chinese Medicine(TCM) Syndrome Research Base, Fujian University of TCM
The First Affiliated Hospital of Anhui University of Chinese Medicine
The First Clinical Medical College of Anhui University of Chinese Medicine